New insights into the genetics of rare diseases
RI-MUHC team builds a new model to study Nager and Rodriguez syndromes, revealing crucial information about the role of the SF3B4 gene
RI-MUHC expands recycling to new heights
Impressive cooperation from research programs brings new success to the RI-MUHC waste recycling and sustainability efforts
New advances in lung cancer treatment
International clinical trial shows perioperative immunotherapy prolongs life in non-small-cell lung cancer patients.
Four RI-MUHC trainees win laurels on a national platform
Congratulations to the many RI-MUHC trainees distinguished recently for their innovative work, and welcome to next year’s candidates!
RI-MUHC researchers introduce a scalable, cost-effective solution for single-cell profiling
An innovative computational tool, scSemiProfiler, makes powerful single-cell sequencing technology more...
Circadian rhythms appear to influence vulnerability to malaria parasites
A new discovery could lead to more effective treatment of malaria and other parasitic diseases.
Exponential growth - 2024 Summer student research event hits record-breaking numbers
A record number of presenters representing every research program contributed to a day filled with...
Eight RI-MUHC trainees earn 2024 EDI award for academic excellence
The awards for Equity, Diversity and Inclusion in health care research recognize the academic excellence...
After a tragic loss, a career devoted to organ regeneration
Darcy Wagner, PhD, leads the charge in advancing bioengineered therapies for acute and chronic lung diseases, centred on advanced 3D bioprinting...
Triple-negative breast cancer: new hope for an existing drug
RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...